Mohammed A. Hamamah-Al
Riyadh, 11451, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Tirzepatide attenuates neurotoxicity by suppressing inflammation, apoptosis and restoring neurotrophin expression in an Alzheimer's disease-like rat model.
Journal: Metabolic brain disease
Published: October 02, 2025
The PPAR-β/δ agonist GW0742 alleviates DNA damage and lupus nephritis in an animal model of systemic lupus erythematosus via restoring DNA repair gene expression.
Journal: Mutation research. Genetic toxicology and environmental mutagenesis
Published: April 11, 2025
Dapagliflozin Mitigated Elevated Disomic and Diploid Sperm in a Mouse Model of Diabetes and Recover the Disrupted Ogg1, Parp1, and P53 Gene Expression.
Journal: Biomedicines
Published: October 01, 2023
Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance.
Journal: International journal of molecular sciences
Published: September 06, 2023
Saxagliptin, a selective dipeptidyl peptidase-4 inhibitor, alleviates somatic cell aneugenicity and clastogenicity in diabetic mice.
Journal: Mutation research. Genetic toxicology and environmental mutagenesis
Published: July 14, 2023
Rituximab alleviates increased disomic sperm in DBA/1J mouse models of rheumatoid arthritis via restoration of redox imbalance.
Journal: Journal of biochemical and molecular toxicology
Published: April 18, 2023
Cadmium Exposure Is Associated with Behavioral Deficits and Neuroimmune Dysfunction in BTBR T+ Itpr3tf/J Mice.
Journal: International journal of molecular sciences
Published: March 06, 2023
S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.
Journal: Multiple sclerosis and related disorders
Published: January 27, 2023
Aneugenic and clastogenic alterations in the DBA/IJ mouse model of rheumatoid arthritis treated with rituximab, an anti-CD20 antibody.
Journal: Mutation research. Genetic toxicology and environmental mutagenesis
Published: December 21, 2022
Rituximab exerts its anti-arthritic effects via inhibiting NF-κB/GM-CSF/iNOS signaling in B cells in a mouse model of collagen-induced arthritis.
Journal: Heliyon
Published: November 02, 2022
Last Updated: 09/26/2026